from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0323c/-

LFCtreatmentdescriptionclass of inhibitor

0.688

Amikacinug/mL Amikacintranslation

0.732

Cap5-10ug/mL Capreomycintranslation

0.095

Rox10-50 ug/mL Roxithromycintranslation

-0.493

SM2-5 ug/mL Streptomycintranslation

1.610

Tet5-10 ug/mL Tetracyclinetranslation

-0.669

Rif0.2-5ug/mL Rifampicintranscription

-0.002

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.189

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.293

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.372

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.520

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.266

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.144

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.892

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.108

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.280

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.056

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.026

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

2.349

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.649

KCN5-20 ug/mL Potassium cyaniderespiration

-2.055

NaN30.2-2 mM Sodium aziderespiration

-0.043

Nigericin50 uM Nigericinrespiration

-0.249

TRC10-150 ug/mL Triclosanrespiration

-0.825

TRZ10-25 ug/mL Thioridazinerespiration

2.142

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

1.466

menadione6-10 ug/mL Menadionerespiration

0.046

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.177

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.061

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.626

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.654

NRP_1Non-replicating persistence stage 1dosRassociated

-1.069

Amp0.2mg/mL AmpicillincellWall

0.095

Cephalexin20-100 ug/mL CephalexincellWall

-0.116

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.662

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.428

EMB10-20 ug/mL EthambutolcellWall

-0.598

Eta12-40 ug/mL EthionamidecellWall

-0.813

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.627

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.252

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.545

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.851

BZA0.12 mg/mL BenzamidearomaticAmides

0.294

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.084

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.724

H2O24 mM hydrogen peroxideDNAdamaging

-0.297

Levo10 ug/mL LevofloxacinDNAdamaging

0.317

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.307

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.578

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.692

UVUV-irradiationDNAdamaging

1.938

ARP41-4 ug/mL Antitubercular compound ARP4?

0.065

Antimycin12.5-50 ug/mL Antimycin A?

-0.453

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.104

PA_110-50 ug/mL Antitubercular compound PA-1?

0.168

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.447

PA8240.2-2 ug/mL PA-824?

0.752

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.212

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.096

Verapamil50 uM Verapamil?

0.237

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.066

methoxatin10-20 ug/mL Methoxatin?